December 11, 2025—Medtronic announced that the Onyx liquid embolic system (LES)—Onyx 18 and Onyx 34—is now indicated in the United States for embolization of the middle meningeal artery (MMA) as an ...

Bendit Technologies, an Israel-based developer of a steerable microcatheter platform, announced that the FDA has granted ...

Biocoat, Inc. announced the formation of Surmodics Services & Technologies, a newly named division of Surmodics, Inc. that ...

Medtronic announced the first commercial use of the Liberant thrombectomy system, which is indicated for the removal of fresh, ...

Teleflex Incorporated announced it has entered into definitive agreements to sell the company’s acute care, interventiona ...

Delcath Systems, Inc. announced the publication of a retrospective study reporting outcomes from patients with liver-dominant ...

The purpose of this commentary is to critically examine the CREST-2 results, discuss their implications for clinical decision-making for asymptomatic carotid artery disease, and guide clinicians ...

Rapid Medical announced the completion of patient enrollment in the multicenter, randomized DISTALS trial assessing the company ...

In a retrospective study evaluating circulating fatty acid synthase (cFAS) as a biomarker for peripheral artery disease (PAD), ...

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.

News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.